PerkinElmer, Inc. (United States) (PKI)
| Market Cap | 16.94B |
| Revenue (ttm) | 3.23B |
| Net Income (ttm) | 412.03M |
| Shares Out | 111.68M |
| EPS (ttm) | 3.69 |
| PE Ratio | 40.98 |
| Forward PE | 18.08 |
| Dividend | $0.28 |
| Dividend Yield | 0.19% |
| Trading Day | January 20 |
| Last Price | $151.19 |
| Previous Close | $149.22 |
| Change ($) | 1.97 |
| Change (%) | 1.32% |
| Day's Open | 150.09 |
| Day's Range | 149.72 - 152.07 |
| Day's Volume | 616,912 |
| 52-Week Range | 66.54 - 160.46 |
PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.
Top Ranked Growth Stocks to Buy for January 14th
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer® New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) from t...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Oxford I...
PerkinElmer's (PKI) acquisition of Oxford Immunotec will expand its portfolio of advanced infectious disease testing solutions.
Shares of PerkinElmer Inc. rose 1.2% toward record territory in premarket trading Monday, after the life sciences diagnostics company provided an upbeat fourth-quarter earnings outlook, citing...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue ...
Is (PKI) Outperforming Other Computer and Technology Stocks This Year?
Oxford Immunotec Global shares surged Thursday after PerkinElmer agreed to buy the diagnostics-focused medical stock for $591 million. This follows its plan to buy Horizon Discovery.
WALTHAM, Mass. & LONDON--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) ("Oxford Immunotec" or the “Company”) are pleased to anno...
PerkinElmer's shares have risen more than 47% in 2020, so why isn't everyone talking about this fast-rising testing company?
Is (PKI) Outperforming Other Computer and Technology Stocks This Year?
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. ...
Top Ranked Growth Stocks to Buy for December 11th
Does PerkinElmer (PKI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Growth Stocks to Buy for December 8th
PerkinElmer (PKI) possesses solid growth attributes, which could help it handily outperform the market.
It will be prudent to invest in Zacks top-Ranked S&P 500 stocks that have skyrocketed year to date with strong potential for 2021. These include DE, HOLX, LB, PKI, IPGP, QRVO.
We have narrowed our search to five mid-cap stocks that have become large caps during the coronavirus hit past eight and a half months. These are: SAM, LB, PKI, UI, GNRC.
Final Trades: Alphabet, PerkinElmer, Ulta Beauty & more
The "Halftime Report" traders give their top picks to watch for the second half. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to C...
Here are a few coronavirus-testing MedTech stocks that investors can scoop up to reap profits amid the pandemic-battered stock market situation.
Is (PKI) Outperforming Other Computer and Technology Stocks This Year?
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., announced today the Lighthouse Lab in Charnwood, Loughborough, England is now processing COVID-19 testing samples as part of the Company's c...
PerkinElmer has been a huge beneficiary of Covid-19 thanks to its diagnostics business. Shares have done well this year, but momentum has been reasonable.
PerkinElmer (PKI) possesses solid growth attributes, which could help it handily outperform the market.
Americas CarMart (CRMT), Best Buy (BBY), IDEXX Laboratories (IDXX) and PerkinElmer (PKI) currently flaunt striking earnings growth and positive estimate revisions.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. announced today that its PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay received CE-IVD marking for the use of saliva as specimen type and th...
As of late, it has definitely been a great time to be an investor in PerkinElmer (PKI).
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a Virtual Life Science...
PerkinElmer's (PKI) new saliva-based collection and asymptomatic test solution receives CE-IVD mark.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer introduces new LC solution bringing together advanced HPLC and UHPLC capabilities with intuitive instrument control and data analysis.
Is (PKI) Outperforming Other Computer and Technology Stocks This Year?
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. today launched its newest ChemDraw® application, ChemOffice®+ Cloud, to accelerate chemistry communication workflows.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launch...
Sales growth is a major indicator of a company's health and ability to sustain business. Let's check out - Tapestry (TPR), Newmont (NEM), Teradyne (TER), Aarons (AAN) & PerkinElmer (PKI) - as ...
Cramer on four coronavirus testing stocks worth owning
"I bet the testing stocks have a lot more room to run," the "Mad Money" host said.
PerkinElmer (PKI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Wolfe Virtua...
PerkinElmer (PKI) possesses solid growth attributes, which could help it handily outperform the market.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel Virtu...
Does PerkinElmer (PKI) have what it takes to be a top stock pick for momentum investors? Let's find out.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million).
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample poo...
PerkinElmer's (PKI) third-quarter results benefit from growth in Diagnostics segment. However, forex remains a woe.
PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q3 2020 Results - Earnings Call Transcript
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended Octo...
PerkinElmer (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Launches immunoassay to help in researcher's fight against neurodegenerative diseases such as Parkinson's and Alzheimer's.
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnost...
WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock October 22, 2020. This divide...
About PKI
PerkinElmer provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and se... [Read more...]
| Industry Diagnostics & Research | Founded 1937 |
| CEO Prahlad Singh | Employees 13,000 |
| Stock Exchange NYSE | Ticker Symbol PKI |
Financial Performance
In 2019, PerkinElmer's revenue was $2.88 billion, an increase of 3.80% compared to the previous year's $2.78 billion. Earnings were $227.56 million, a decrease of -4.36%.
Analyst Forecasts
According to 16 analysts, the average rating for PerkinElmer stock is "Buy." The 12-month stock price forecast is 155.40, which is an increase of 2.78% from the latest price.